Clostridium difficile infection (CDI) is diagnosed with the help of conventional laboratory testing methods, however, rapid point-of-care diagnostic tests are also available, which can save time and costs significantly. Diagnostic assays used for detection of CDI include enzyme immunoassays (EIAs) for toxins A/B. However, these are no longer considered stand-alone primary tests due to poor sensitivity. Other tests include glutamate dehydrogenase enzyme immunoassay and molecular assay based on polymerase chain reaction. Isothermal amplification technology has also been approved by the U.S. Food & Drug Administration for diagnosis of CDI. Manufacturers such as Cepheid, BD Diagnostics, DiaSorin, Inc., Abbott Laboratories, Thermo Fisher Diagnostics, and Luminex Corporation offer advanced diagnostic tests for clostridium difficile infection. For instance, Cepheid GeneXpert test, Nanosphere Verigene SP by Luminex Corporation offer sensitivity and timely results for clostridium difficile infection.
Market Dynamics
Factors such as rising prevalence of clostridium difficile infection, availability of precise and advanced diagnostic techniques such as real time-polymerase chain reaction (RT-PCR), and presence of generic versions of standard antibiotics such as metronidazole is expected to boost growth of the clostridium difficile diagnostics and treatment market over the forecast period. Furthermore, various organizations and manufacturers are working towards increasing awareness about clostridium difficile infection and its severity. For instance, in March 2018, C Diff Foundation awarded its “Making a Difference” award to CutisPharma, Inc.—a pharmaceutical company, for contribution of the company towards increasing awareness and expanding treatment options.
Key features of the study:
This report provides in-depth analysis of clostridium difficile diagnostics and treatment market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017–2025), considering 2016 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global clostridium difficile diagnostics and treatment market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key companies covered as a part of this study include Roche AG, Thermo Fisher Scientific Inc., Merck & Co., Inc., Pfizer, Inc., Actelion Pharmaceuticals, Abbott Laboratories, Trinity Biotech, Summit Therapeutics, Sanofi S.A., Novartis AG, and AstraZeneca Plc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The global clostridium difficile diagnostics and treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the clostridium difficile diagnostics and treatment market
Detailed Segmentation:
Global Clostridium Difficile Diagnostics and Treatment Market, By Product Type:
By Drug
Metronidazole
Vancomycin
Fidaxomicin
Bezlotoxumab
By Diagnostic Test
Enzyme Immunoassays
Real-Time Polymerase Chain Reaction (RT-PCR)
Nucleic Amplification Tests (NAAT)
Others
Global Clostridium Difficile Diagnostics and Treatment Market, By Distribution Channel:
Hospitals & Clinics
Diagnostic Laboratories
Pharmacies
Global Clostridium Difficile Diagnostics and Treatment Market, By Geography:
North America
By Product Type:
By Drug
Metronidazole
Vancomycin
Fidaxomicin
Bezlotoxumab
By Diagnostic Test
Enzyme Immunoassays
Real-Time Polymerase Chain Reaction (RT-PCR)
Nucleic Amplification Tests (NAAT)
Others
By Distribution Channel:
Hospitals & Clinics
Diagnostic Laboratories
Pharmacies
By Country:
U.S.
Canada
Europe
By Product Type:
By Drug
Metronidazole
Vancomycin
Fidaxomicin
Bezlotoxumab
By Diagnostic Test
Enzyme Immunoassays
Real-Time Polymerase Chain Reaction (RT-PCR)
Nucleic Amplification Tests (NAAT)
Others
By Distribution Channel:
Hospitals & Clinics
Diagnostic Laboratories
Pharmacies
By Country:
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
By Product Type:
By Drug
Metronidazole
Vancomycin
Fidaxomicin
Bezlotoxumab
By Diagnostic Test
Enzyme Immunoassays
Real-Time Polymerase Chain Reaction (RT-PCR)
Nucleic Amplification Tests (NAAT)
Others
By Distribution Channel:
Hospitals & Clinics
Diagnostic Laboratories
Pharmacies
By Country:
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
By Product Type:
By Drug
Metronidazole
Vancomycin
Fidaxomicin
Bezlotoxumab
By Diagnostic Test
Enzyme Immunoassays
Real-Time Polymerase Chain Reaction (RT-PCR)
Nucleic Amplification Tests (NAAT)
Others
By Distribution Channel:
Hospitals & Clinics
Diagnostic Laboratories
Pharmacies
By Country:
Brazil
Mexico
Rest of Latin America
Middle East
By Product Type:
By Drug
Metronidazole
Vancomycin
Fidaxomicin
Bezlotoxumab
By Diagnostic Test
Enzyme Immunoassays
Real-Time Polymerase Chain Reaction (RT-PCR)
Nucleic Amplification Tests (NAAT)
Others
By Distribution Channel:
Hospitals & Clinics
Diagnostic Laboratories
Pharmacies
By Country:
GCC
Israel
Rest of Middle East
Africa
By Product Type:
By Drug
Metronidazole
Vancomycin
Fidaxomicin
Bezlotoxumab
By Diagnostic Test
Enzyme Immunoassays
Real-Time Polymerase Chain Reaction (RT-PCR)
Nucleic Amplification Tests (NAAT)
Others
By Distribution Channel:
Hospitals & Clinics
Diagnostic Laboratories
Pharmacies
By Country:
Central Africa
South Africa
North Africa
Company Profiles
Roche AG *
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Thermo Fisher Scientific
Merck & Co., Inc.
Pfizer, Inc.
Actelion Pharmaceuticals, Inc.
Abbott Laboratories
Trinity Biotech
Summit Therapeutics
Sanofi S.A.
Novartis AG
AstraZeneca Plc
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objective and Assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
? Market Definition and Scope
o Executive Summary
? Market Snippet, By Product Type
? Market Snippet, By Distribution Channel
? Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
? Drivers
? Restraints
? Market Opportunities
o Impact Analysis
o Product Launches
o Pipeline Analysis
o Alternative Therapies
o Point-of-Care Vs. Conventional Diagnostic Tests
o Drug Resistant Clostridium Difficile Infection
4. Global Clostridium Difficile Diagnostics and Treatment Market, By Product Type, 2015-2025 (US$ Mn)
o Introduction
? Market Share Analysis, 2016 and 2025 (%)
? Y-o-Y Growth Analysis, 2016-2025
? Segment Trends
o By Drug
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Mn)
? Metronidazole
? Vancomycin
? Fidaxomicin
? Bezlotoxumab
o By Diagnostic Test
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Mn)
? Enzyme Immunoassays
? Real-Time Polymerase Chain Reaction (RT-PCR)
? Nucleic Amplification Tests (NAAT)
? Others
5. Global Clostridium Difficile Diagnostics and Treatment Market, By Distribution Channel, 2015-2025 (US$ Mn)
o Introduction
? Market Share Analysis, 2016 and 2025 (%)
? Y-o-Y Growth Analysis, 2016-2025
? Segment Trends
o Hospitals & Clinics
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Mn)
o Diagnostic Laboratories
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Mn)
o Pharmacies
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Mn)
6. Global Clostridium Difficile Diagnostics and Treatment Market, By Regions, 2015-2025 (US$ Mn)
o Introduction
? Market Share Analysis, By Region, 2016 and 2025 (%)
? Y-o-Y Growth Analysis, For Regions, 2016-2025
o North America
? Market Size and Forecast, By Product Type, 2015-2025 (US$ Mn)
? Market Size and Forecast, By Distribution Channel, 2015-2025 (US$ Mn)
? Market Size and Forecast, By Country, 2015-2025 (US$ Mn)
? U.S.
? Canada
o Europe
? Market Size and Forecast, By Product Type, 2015-2025 (US$ Mn)
? Market Size and Forecast, By Distribution Channel, 2015-2025 (US$ Mn)
? Market Size and Forecast, By Country, 2015-2025 (US$ Mn)
? U.K.
? Germany
? Italy
? France
? Spain
? Russia
? Rest of Europe
o Asia Pacific
? Market Size and Forecast, By Product Type, 2015-2025 (US$ Mn)
? Market Size and Forecast, By Distribution Channel, 2015-2025 (US$ Mn)
? Market Size and Forecast, By Country, 2015-2025 (US$ Mn)
? China
? India
? Japan
? ASEAN
? Australia
? South Korea
? Rest of APAC
o Latin America
? Market Size and Forecast, By Product Type, 2015-2025 (US$ Mn)
? Market Size and Forecast, By Distribution Channel, 2015-2025 (US$ Mn)
? Market Size and Forecast, By Country, 2015-2025 (US$ Mn)
? Brazil
? Mexico
? Rest of Latin America
o Africa
? Market Size and Forecast, By Product Type, 2015-2025 (US$ Mn)
? Market Size and Forecast, By Distribution Channel, 2015-2025 (US$ Mn)
? Market Size and Forecast, By Country, 2015-2025 (US$ Mn)
? Central Africa
? South Africa
? North Africa
o Middle East
? Market Size and Forecast, By Product Type, 2015-2025 (US$ Mn)
? Market Size and Forecast, By Distribution Channel, 2015-2025 (US$ Mn)
? Market Size and Forecast, By Country, 2015-2025 (US$ Mn)
? GCC
? Israel
? Rest of Middle East
7. Competitive Landscape
o Heat Map Analysis
o Company Profiles
? Roche AG
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? Thermo Fisher Scientific
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? Merck & Co., Inc.
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? Pfizer, Inc.
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? Actelion Pharmaceuticals, Inc.
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? Abbott Laboratories
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? Trinity Biotech Plc
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? Summit Therapeutics
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? Sanofi S.A.
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? Novartis AG
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? AstraZeneca Plc
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
8. Section
o References
o Research Methodology
o About us and Sales Contact
*Browse 37 market data tables and 43 figures on "Clostridium Difficile Diagnostics and Treatment Market - Global forecast to 2025".
Request Discount 
Inquire Before Buy
